NREMX
Price
$19.09
Change
-$0.26 (-1.34%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

NREMX vs RNWFX

Header iconNREMX vs RNWFX Comparison
Open Charts NREMX vs RNWFXBanner chart's image
Neuberger Berman Emerg Mkts Eq R6
Price$19.09
Change-$0.26 (-1.34%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NREMX vs RNWFX Comparison Chart
Loading...
VS
NREMX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NREMX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. NREMX (203M). RNWFX pays higher dividends than NREMX: RNWFX (1.51) vs NREMX (1.38). NREMX was incepted earlier than RNWFX: NREMX (11 years) vs RNWFX (22 years). NREMX is a more actively managed with annual turnover of: 58.00 vs. RNWFX (32.00). NREMX has a lower initial minimum investment than RNWFX: NREMX (0) vs RNWFX (250). NREMX annual gain was more profitable for investors over the last year : 14.90 vs. RNWFX (11.53). RNWFX return over 5 years is better than : 22.38 vs. NREMX (6.39).
NREMXRNWFXNREMX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years22 years-
Gain YTD11.3997.245157%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets203M60.1B0%
Annual Yield % from dividends1.381.5192%
Returns for 1 year14.9011.53129%
Returns for 3 years-15.60-15.44101%
Returns for 5 years6.3922.3829%
Returns for 10 years16.4435.7146%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio